Skip to main content

Table 1 Characteristics of study participants (N = 487)

From: Hypernatremia at admission predicts poor survival in patients with terminal cancer: a retrospective cohort study

 

Median (IQR) or n (%)

Reference range

Age, yrs

70 (59–79)

 

Female sex

219 (45.0)

 

Cancer site

 Gastrointestinal tract

127 (26.1)

 

 Hepatobiliary/pancreatic

118 (24.2)

 

 Lung

108 (22.2)

 

 Urogenital tract

57 (11.7)

 

 Others

77 (15.8)

 

ECOG-PS

  ≤ 2

115 (23.6)

 

 3

189 (38.8)

 

 4

183 (37.6)

 

Active infectiona

164 (33.7)

 

Laboratory parameter

 White blood cells, 103/mm3

9.1 (6.3–12.7)

3.8–10

 Neutrophils, %

78.9 (72.0–85.7)

50–75

 Lymphocytes, %

11.2 (6.8–17.4)

20–44

 Hemoglobin, g/dL

10.1 (8.8–11.7)

13–17

 Platelets, 103/mm3

227 (154–323)

150–400

 Creatinine, mg/dL

0.8 (0.5–1.2)

0.5–1.2

 Albumin, g/dL

3.2 (2.8–3.7)

3.5–5.2

 Total bilirubin, mg/dL

0.7 (0.5–1.4)

0.2–1.2

 PT/INR

1.2 (1.1–1.3)

0.8–1.2

 C-reactive protein, mg/dL

5.2 (2.3–12.9)

0–0.5

 Sodium, mEq/L

134 (130–137)

135–145

 Potassium, mEq/L

4.2 (3.8–4.6)

3.5–5.5

Censoredb

19 (3.9)

 

Survival time, days

26 (14–45)

 
  1. ECOG-PS Eastern Cooperative Oncology Group performance status, IQR interquartile range, PT/INR prothrombin time/international normalized ratio
  2. aDetermined by the use of antibiotics
  3. bNo available information for survival by discharge or transfer